Labcorp Plasma Focus Liquid Biopsy Test Launches
Labcorp has launched Labcorp Plasma Focus, a new liquid biopsy test enabling targeted therapy selection for solid tumors.
Read MorePosted by Chris Wolski | Jun 1, 2023 | Cancer |
Labcorp has launched Labcorp Plasma Focus, a new liquid biopsy test enabling targeted therapy selection for solid tumors.
Read MorePosted by Chris Wolski | Jun 1, 2023 | Prostate |
The accuracy of PSA in prostate cancer screening can be improved by accounting for genetic factors that are not associated with cancer.
Read MorePosted by Melanie Hamilton-Basich | May 31, 2023 | Molecular Diagnostics |
GeneDx now offers its GenomeXpress and GenomeSeqDx whole genome sequencing tests with buccal swabs as an alternative sample collection option for biological parents and other immediate family members.
Read MorePosted by Melanie Hamilton-Basich | May 30, 2023 | Lung Cancer |
The first-generation lung cancer classification model based on gene expression data is already available for use within Qlucore Insights.
Read MorePosted by Melanie Hamilton-Basich | May 24, 2023 | Lab Automation |
Clear Dx Microbial Surveillance WGS is a fully automated, end-to-end whole genome sequencing solution for bacterial and fungal isolates.
Read More